Patients ’ Perspectives on Psychiatric Pharmacogenetic Testing

This study sought to assess genotyped
patients’ perspectives and experiences with psychiatric PGx
testing.
Methods Individual semi-structured interviews were conducted among
patients with depression who had undergone psychiatric PGx testing. The
audio-recorded interviews were transcribed and analyzed inductively and
deductively for salient themes.
Results Twenty patients (100% Caucasian, 60% female,
mean age 39±18 years) were interviewed. The majority of the PGx
tests were provider-initiated for patients who failed multiple
pharmacotherapies (50%) and/or had medication intolerances
(45%). Patients’ pre-testing expectations ranged from
hopefulness to indifference to skepticism. Their post-testing experiences
varied from optimism to disappointment, with the perceived value of the test
influenced by the results and cost of the test.
Discussion Genotyped patients had mixed perspectives, expectations,
and experiences with psychiatric PGx testing. Their perceived value of the
test was influenced by the test outcomes and its cost. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text

Source: Pharmacopsychiatry - June 23, 2020 Category: Psychiatry Authors: Liko, Ina Lai, Erika Griffin, Rachel J. Aquilante, Christina L. Lee, Yee Ming Tags: Original Paper Source Type: research